This study also demonstrated the same CIP2A-PP2A-AKT cascade in NSCLC xenografts treated with Afatanib and showed that in clinical samples from NSCLC resections CIP2A expression predicted poor prognosis and was correlated with Elk-1 expression [94]. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.